Cardiome Pharma (CRME) Tops Q3 EPS by 1c

November 7, 2016 8:10 AM EST
Get Alerts CRME Hot Sheet
Trade CRME Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Cardiome Pharma (NASDAQ: CRME) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $5.68 million.

For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment